• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌概述:病理学与遗传学。

An overview of renal cell cancer: pathology and genetics.

机构信息

Institute of Surgical Pathology, Department Pathology, University Hospital Zurich, Schmelzbergstrasse 12, CH-8091 Zurich, Switzerland.

出版信息

Semin Cancer Biol. 2013 Feb;23(1):3-9. doi: 10.1016/j.semcancer.2012.06.006. Epub 2012 Jun 18.

DOI:10.1016/j.semcancer.2012.06.006
PMID:22722066
Abstract

Renal cell carcinoma is a group of malignancies arising from the epithelium of the renal tubules. The pattern of somatic mutations in kidney tumors has been extensively investigated. In the current 2004 WHO classification, the molecular background of a renal tumor has become, in addition to histopathology, a major criterion for tumor classification. The goal of this review is to discuss morphology and genetics of adult renal epithelial cancer included in the 2004 WHO classification and to mention renal tumor types, which are not considered in the current WHO classification. Further, pathologic considerations with clinical and prognostic implications are provided.

摘要

肾细胞癌是一组起源于肾小管上皮的恶性肿瘤。肾肿瘤的体细胞突变模式已得到广泛研究。在当前的 2004 年世界卫生组织(WHO)分类中,肿瘤的分子背景除了组织病理学外,已成为肿瘤分类的主要标准。本篇综述的目的是讨论 2004 年 WHO 分类中包含的成人肾上皮癌的形态学和遗传学,并提及当前 WHO 分类中未考虑的肾肿瘤类型。此外,还提供了具有临床和预后意义的病理考虑。

相似文献

1
An overview of renal cell cancer: pathology and genetics.肾细胞癌概述:病理学与遗传学。
Semin Cancer Biol. 2013 Feb;23(1):3-9. doi: 10.1016/j.semcancer.2012.06.006. Epub 2012 Jun 18.
2
Pathology of renal cell carcinoma: an update.肾细胞癌的病理学:最新进展
Anal Quant Cytopathol Histpathol. 2013 Apr;35(2):61-76.
3
Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.肾小管囊性癌与乳头状肾细胞癌密切相关:对病理分类的意义
Am J Surg Pathol. 2009 Dec;33(12):1840-9. doi: 10.1097/PAS.0b013e3181be22d1.
4
Renal tumours: the new order.肾肿瘤:新秩序
N Z Med J. 1998 Aug 28;111(1072):307-9.
5
[Molecular genetic classification of renal cell carcinoma].[肾细胞癌的分子遗传学分类]
Verh Dtsch Ges Pathol. 2002;86:28-39.
6
[Chromosome analysis of renal cell carcinoma].[肾细胞癌的染色体分析]
Rinsho Byori. 1989 Feb;Spec No 80:209-17.
7
Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity.集合管癌与肾髓质癌:对疾病分类学和生物学清晰度的呼吁。
Am J Surg Pathol. 2014 Jul;38(7):871-4. doi: 10.1097/PAS.0000000000000222.
8
New renal cell carcinomas in the International Society of Urological Pathology Vancouver classification of renal neoplasia.国际泌尿病理学会温哥华肾肿瘤分类中的新型肾细胞癌。
J Urol. 2014 Feb;191(2):473-4. doi: 10.1016/j.juro.2013.11.017. Epub 2013 Nov 11.
9
Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.透明细胞管状乳头状肾细胞癌:36 例独特的低级肾上皮肿瘤的研究。
Am J Surg Pathol. 2010 Nov;34(11):1608-21. doi: 10.1097/PAS.0b013e3181f2ee0b.
10
Significance of gene expression analysis of renal cell carcinoma.肾细胞癌基因表达分析的意义
Expert Rev Anticancer Ther. 2006 Feb;6(2):293-9. doi: 10.1586/14737140.6.2.293.

引用本文的文献

1
Uncovering the research evolution and hotspots of metabolism in renal cell carcinoma over the last decade.揭示过去十年间肾细胞癌代谢的研究进展与热点。
Front Oncol. 2025 Aug 26;15:1537805. doi: 10.3389/fonc.2025.1537805. eCollection 2025.
2
Bispecific antibodies as powerful immunotherapeutic agents for urological cancers: Recent innovations based on preclinical and clinical evidence.双特异性抗体作为治疗泌尿系统癌症的强大免疫治疗剂:基于临床前和临床证据的最新创新
Int J Biol Sci. 2025 Jan 27;21(4):1410-1435. doi: 10.7150/ijbs.96155. eCollection 2025.
3
NPS-1034 Exerts Therapeutic Efficacy in Renal Cell Carcinoma Through Multiple Targets of MET, AXL, and TNFRSF1A Signaling in a Metastatic Model.
NPS-1034 通过 MET、AXL 和 TNFRSF1A 信号通路的多个靶点在转移性模型中发挥治疗肾细胞癌的疗效。
Cells. 2024 Oct 17;13(20):1713. doi: 10.3390/cells13201713.
4
Combined Clear Cell Renal Cell Carcinoma and Chromophobe Renal Cell Carcinoma: A Case Report.透明细胞肾细胞癌与嫌色细胞肾细胞癌合并:一例报告
Cureus. 2024 Jun 8;16(6):e61940. doi: 10.7759/cureus.61940. eCollection 2024 Jun.
5
Matrix- and Surface-Assisted Laser Desorption/Ionization Mass Spectrometry Methods for Urological Cancer Biomarker Discovery-Metabolomics and Lipidomics Approaches.用于泌尿系统癌症生物标志物发现的基质辅助激光解吸/电离质谱法和表面辅助激光解吸/电离质谱法——代谢组学和脂质组学方法
Metabolites. 2024 Mar 20;14(3):173. doi: 10.3390/metabo14030173.
6
Implications of MTHFD2 expression in renal cell carcinoma aggressiveness.MTHFD2 表达与肾细胞癌侵袭性的关系。
PLoS One. 2024 Feb 29;19(2):e0299353. doi: 10.1371/journal.pone.0299353. eCollection 2024.
7
Therapeutic Efficacy of YM155 to Regulate an Epigenetic Enzyme in Major Subtypes of RCC.YM155 调节主要 RCC 亚型中一种表观遗传学酶的治疗效果。
Int J Mol Sci. 2023 Dec 22;25(1):216. doi: 10.3390/ijms25010216.
8
Exploring the Potential of Rosemary Derived Compounds (Rosmarinic and Carnosic Acids) as Cancer Therapeutics: Current Knowledge and Future Perspectives.探索迷迭香衍生化合物(迷迭香酸和鼠尾草酸)作为癌症治疗药物的潜力:当前知识与未来展望
Biomol Ther (Seoul). 2024 Jan 1;32(1):38-55. doi: 10.4062/biomolther.2023.054.
9
Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer.m6A 修饰在调控癌症中 PI3K/AKT 信号通路中的作用。
J Transl Med. 2023 Nov 1;21(1):774. doi: 10.1186/s12967-023-04651-0.
10
Stage-specific coexpression network analysis of Myc in cohorts of renal cancer.Myc 在肾细胞癌队列中的阶段特异性共表达网络分析。
Sci Rep. 2023 Jul 22;13(1):11848. doi: 10.1038/s41598-023-38681-x.